Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenScript's rapid response with the development of their cPass SARS-CoV-2 nAb Detection Kit and SARS-CoV-2 qPCR kit. Gain insights into the diagnostic development workflow and learn about GenScript's cutting-edge solutions for target identification, assay development, optimization, and production that made assay development possible. We will also share case studies showcasing how customers have leveraged GenScript for IVD development including a highlight of our recent research grant awardees and their diagnostic projects.

In this talk, you will: 

1. Learn about GenScript's development of two COVID-19 related diagnostics.

2. Learn about GenScript's IVD development solutions at each stage of development.

3. Hear about other research in action with GenScript support.